A new oral contraceptive based on the normophasic method.
62 women were treated for 554 cycles with normophasic oral contraceptive Fisioquens. A treatment cycle consists of 7 tablets of 0.05 mg ethinyloestradiol, followed by 15 tablets with a combination of 0.05 mg ethinyl-oestradiol and 1 mg lynestrenol. No pregnancies occurred. Both tolerance of the preparation and cycle control were good. Irregular bleeding occurred sporadically. Various side-effects diminished during treatment and even disappeared completely. Fisioquens appears to be a reliable contraceptive with a minimum of side-effects.
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects; D004338:Drug Combinations; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced
D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D008234:Lynestrenol